Evaluation of the Potential Effect of Iptakalim Hydrochloride on the QT Interval in Single- and

Nan Bai1, Jin Wang1, Haoyue Che1

  • 1Chinese People's Liberation Army General Hospital, Medicine Clinical Research Center, Beijing, China.

Insights

Iptakalim hydrochloride (ITKL) did not prolong the QT interval in healthy subjects. This study assessed cardiac repolarization effects of ITKL, a hypertension drug, finding no significant QTc interval changes at therapeutic doses.

Area of Science:

  • Pharmacology
  • Cardiology
  • Clinical Trials

Background:

  • Cardiotoxicity is a major reason for drug withdrawal.
  • QT interval prolongation is a key indicator of drug-induced cardiotoxicity.
  • Assessing cardiac repolarization risk is vital for new antihypertensive drugs like Iptakalim hydrochloride (ITKL).

Purpose of the Study:

  • To evaluate the effect of Iptakalim hydrochloride (ITKL) on the corrected QT (QTc) interval.
  • To investigate the correlation between ITKL plasma concentration and QTc interval changes.
  • To determine the cardiac safety profile of ITKL regarding repolarization in healthy subjects.

Main Methods:

  • A randomized, double-blind, placebo-controlled study.
  • Single and multiple oral doses of ITKL (5-20 mg) administered to 83 healthy subjects.
  • Electrocardiograms (ECGs) and blood samples collected to monitor QTc interval and ITKL levels.

Main Results:

  • No significant prolongation of the QTc interval was observed at any tested plasma level of ITKL.
  • The maximum observed ΔΔQTcF effect was below the exclusion threshold of 10 milliseconds.
  • Even at twice the therapeutic dose (20 mg), ITKL did not affect QTc interval.

Conclusions:

  • Iptakalim hydrochloride (ITKL) does not prolong the QT interval in healthy subjects within the therapeutic dose range.
  • ITKL demonstrates a favorable cardiac safety profile concerning repolarization.
  • Further clinical evaluation can proceed with confidence in ITKL's cardiac safety.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
67
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
69
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.5K
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.4K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
63
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
343